SenesTech Inc (SNES) Receives Average Recommendation of “Strong Buy” from Brokerages

SenesTech Inc (NASDAQ:SNES) has received an average broker rating score of 1.00 (Strong Buy) from the one analysts that provide coverage for the stock, Zacks Investment Research reports. One equities research analyst has rated the stock with a strong buy recommendation.

Brokerages have set a one year consensus target price of $2.50 for the company and are predicting that the company will post ($0.11) EPS for the current quarter, according to Zacks. Zacks has also given SenesTech an industry rank of 155 out of 256 based on the ratings given to its competitors.

Separately, Zacks Investment Research cut shares of SenesTech from a “hold” rating to a “sell” rating in a report on Friday, November 16th.

A hedge fund recently raised its stake in SenesTech stock. Vanguard Group Inc grew its position in SenesTech Inc (NASDAQ:SNES) by 35.3% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 162,808 shares of the company’s stock after buying an additional 42,500 shares during the quarter. Vanguard Group Inc owned approximately 0.69% of SenesTech worth $112,000 at the end of the most recent quarter. Institutional investors own 12.50% of the company’s stock.

Shares of SNES traded up $0.01 during mid-day trading on Friday, hitting $0.65. The company’s stock had a trading volume of 23,315 shares, compared to its average volume of 84,300. The stock has a market capitalization of $13.73 million, a P/E ratio of -0.58 and a beta of 0.38. The company has a debt-to-equity ratio of 0.03, a current ratio of 9.02 and a quick ratio of 7.88. SenesTech has a fifty-two week low of $0.30 and a fifty-two week high of $2.37.

SenesTech (NASDAQ:SNES) last announced its quarterly earnings data on Monday, November 12th. The company reported ($0.14) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.11) by ($0.03). The business had revenue of $0.11 million during the quarter. SenesTech had a negative return on equity of 169.43% and a negative net margin of 6,510.67%. As a group, equities research analysts forecast that SenesTech will post -0.66 EPS for the current fiscal year.

About SenesTech

SenesTech, Inc develops a technology for managing animal pest populations through fertility control. The company focuses on commercializing ContraPest, a fertility control product for use in controlling rat populations. It is also developing a pipeline of fertility control and animal health products, including feral animal fertility control, non-surgical spay and neutering, boar taint, and animal cancer treatment.

Featured Article: How to Use the New Google Finance Tool

Get a free copy of the Zacks research report on SenesTech (SNES)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with's FREE daily email newsletter.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit